Exploring New Approaches to Protecting and Restoring Vision
Retinal cell therapy explores the replacement or regeneration of damaged retinal cells to help restore visual function.
Transforming the Future of Retinal Care
Cell therapy is an emerging area of retinal research that aims to repair, replace or support damaged retinal cells. Because the retina has limited ability to naturally replace cells lost through disease, researchers are exploring whether laboratory-grown cells can be introduced into the eye to restore or preserve retinal function.
Research is focusing particularly on replacing or supporting photoreceptors, the light-sensitive cells responsible for vision, and retinal pigment epithelial (RPE) cells, which help maintain photoreceptor health.
Potential applications include inherited retinal diseases (IRDs), Age-Related Macular Degeneration (AMD), Geographic Atrophy and other retinal degenerative conditions.
Although many cell-based treatments remain in the research and clinical trial stages, advances in regenerative medicine offer potential new approaches to preserving or improving vision.
Retinal Pigment Epithelium (RPE) Cell Therapy
The RPE is a specialised layer of cells that supports photoreceptors and plays an essential role in maintaining retinal health.
In conditions such as geographic atrophy and some forms of AMD, damage to RPE cells contributes to progressive vision loss.
Researchers are investigating whether transplanted RPE cells could:
- Replace damaged cells
- Support remaining retinal tissue
- Slow disease progression
Photoreceptor Replacement Therapy
Photoreceptors are the retinal cells responsible for detecting light and enabling vision.
In inherited retinal diseases, photoreceptor degeneration is a major cause of vision loss.
Researchers are exploring whether replacement photoreceptor cells could:
- Restore retinal signalling
- Improve visual function
- Replace cells lost through degeneration
This approach remains challenging because new cells must integrate correctly with existing retinal structures.
Cell Sources and Delivery Approaches
Researchers are investigating different sources of cells for retinal therapies, particularly:
- Stem cell-derived cells: Stem cells can be developed in the laboratory into specialised retinal cells, including retinal pigment epithelial (RPE) cells and photoreceptor-like cells.
- Induced pluripotent stem cells (iPSCs): These are adult cells reprogrammed to behave like stem cells. They may offer opportunities for personalised research and treatment approaches.
Delivering cells safely and effectively is another key challenge. Approaches under investigation include surgical transplantation beneath the retina, cell delivery systems, tissue-engineered implants and supportive biomaterials designed to improve cell survival. For treatment to succeed, transplanted cells must survive, integrate with retinal structures and function appropriately.
Current Research and Challenges
Cell therapies for retinal conditions remain largely experimental, with research and clinical trials investigating which cells are most suitable, how to improve their survival and integration, and which patients may benefit.
Key challenges include preventing immune rejection, achieving long-term cell survival, ensuring transplanted cells function correctly, developing safe and scalable manufacturing processes and establishing the most appropriate timing for treatment.
Although cell therapy is not yet widely available for retinal conditions, continued research and collaboration are advancing regenerative approaches and exploring their potential to preserve or improve vision.
The Future of Cell Therapy
Cell therapy represents an exciting frontier in retinal research.
Future developments may include:
- Improved methods for producing retinal cells
- More targeted delivery approaches
- Combination therapies using gene and cell-based approaches
- Personalised regenerative treatments
Through collaboration between researchers, clinicians, patients, and advocacy organisations, cell therapy research continues to move towards the goal of developing meaningful treatments for people affected by retinal conditions.
-
close